|
Q4 FY2026
As of Jun 30, 2026
|
Q4 FY2025
As of Jun 30, 2025
|
Q4 FY2024
As of Jun 30, 2024
|
Q4 FY2023
As of Jun 30, 2023
|
Q4 FY2022
As of Jul 22, 2022
|
Q4 FY2021
As of Jun 30, 2021
|
Q4 FY2020
As of Jun 30, 2020
|
Q4 FY2019
As of Jun 30, 2019
|
|
|---|---|---|---|---|---|---|---|---|
| Investment properties | ||||||||
| Property, plant and equipment | ||||||||
| Trading properties | ||||||||
| Intangible assets | ||||||||
| Group of assets held for sale | ||||||||
| Right of use assets | ||||||||
| Biological assets | ||||||||
| Investment in associates and joint ventures | ||||||||
| Deferred income tax assets | ||||||||
| Income tax and credits | ||||||||
| Income tax credit | ||||||||
| Restricted assets | ||||||||
| Trade and other receivables | ||||||||
| Investment in financial assets | ||||||||
| Derivative financial instruments | ||||||||
| Total non-current assets | ||||||||
| Current assets | ||||||||
| Trading properties | ||||||||
| Inventories | ||||||||
| Cash and cash equivalents | ||||||||
| Total current assets | ||||||||
| TOTAL ASSETS | ||||||||
| SHAREHOLDERS' EQUITY | ||||||||
| Shareholders' equity (according to corresponding statement) | ||||||||
| Non-controlling interest | ||||||||
| TOTAL SHAREHOLDERS' EQUITY | ||||||||
| Non-current liabilities | ||||||||
| Trade and other payables | ||||||||
| Borrowings | ||||||||
| Deferred income tax liabilities | ||||||||
| Provisions | ||||||||
| Payroll and social security liabilities | ||||||||
| Lease liabilities | ||||||||
| Total non-current liabilities | ||||||||
| Trade and other payables | ||||||||
| Income tax liabilities | ||||||||
| Total Current liabilities | ||||||||
| TOTAL LIABILITIES | ||||||||
| TOTAL SHAREHOLDERS' EQUITY AND LIABILITIES | ||||||||
Loading...
